Remogliflozin Etabonate Improves Fatty Liver Disease in Diet-Induced Obese Male Mice

Remogliflozin Etabonate Improves Fatty Liver Disease in Diet-Induced Obese Male Mice

Item
http://www.wikidata.org/entity/Q42107886
Non-alcoholic fatty liver disease: an emerging driving force in chronic kidney disease.Ipragliflozin Improves Hepatic Steatosis in Obese Mice and Liver Dysfunction in Type 2 Diabetic Patients Irrespective of Body Weight Reduction.Novel antidiabetic medications for non-alcoholic fatty liver disease with type 2 diabetes mellitus.Causes and consequences of endoplasmic reticulum stress in rheumatic disease.Effect of sodium glucose cotransporter 2 inhibitor on liver function tests in Japanese patients with non-alcoholic fatty liver disease and type 2 diabetes mellitus.SGLT2 Inhibition by Empagliflozin Promotes Fat Utilization and Browning and Attenuates Inflammation and Insulin Resistance by Polarizing M2 Macrophages in Diet-induced Obese Mice.Dapagliflozin slows the progression of the renal and liver fibrosis associated with type 2 diabetes.Canagliflozin, an SGLT2 inhibitor, attenuates the development of hepatocellular carcinoma in a mouse model of human NASH.Emerging roles of SGLT2 inhibitors in obesity and insulin resistance: Focus on fat browning and macrophage polarization.The Sodium-Glucose Cotransporter 2 Inhibitor Dapagliflozin Prevents Renal and Liver Disease in Western Diet Induced Obesity Mice.Therapeutic approaches targeting inflammation for diabetes and associated cardiovascular risk.Efficacy of canagliflozin against nonalcoholic fatty liver disease: a prospective cohort study
P2860

Remogliflozin Etabonate Improves Fatty Liver Disease in Diet-Induced Obese Male Mice

Item
http://www.wikidata.org/entity/Q42107886
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
2015年學術文章
@zh
2015年學術文章
@zh-hant
name
Remogliflozin Etabonate Improves Fatty Liver Disease in Diet-Induced Obese Male Mice
@en
Remogliflozin Etabonate Improves Fatty Liver Disease in Diet-Induced Obese Male Mice
@nl
type
label
Remogliflozin Etabonate Improves Fatty Liver Disease in Diet-Induced Obese Male Mice
@en
Remogliflozin Etabonate Improves Fatty Liver Disease in Diet-Induced Obese Male Mice
@nl
prefLabel
Remogliflozin Etabonate Improves Fatty Liver Disease in Diet-Induced Obese Male Mice
@en
Remogliflozin Etabonate Improves Fatty Liver Disease in Diet-Induced Obese Male Mice
@nl
P1433
P1476
P2093
P2860
P304
P31
P356
P433
P478
P50
P577
P698
P921
P932
P356
P1433
P1476
Remogliflozin Etabonate Improves Fatty Liver Disease in Diet-Induced Obese Male Mice
@en
P2093
P2860
P304
P31
P356
10.1016/J.JCEH.2015.02.005
P433
P478
P50
P577
P698
P921
P932